Financial Times: Hopes rise for malaria vaccine as oil companies fund trials
“Two U.S. oil companies are pouring millions of dollars into the trials of a promising malaria vaccine in Equatorial Guinea in a rare sign of foreign investors trying to help tackle one of Africa’s biggest health scourges. Marathon Oil and Noble Energy have teamed up with the government of Equatorial Guinea to fund trials of one of the most hotly tipped malaria vaccines in development…” (Ward, 6/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.